The role of SEC14L4 in esophageal squamous cell cancer: insights into clinical relevance and molecular pathways
High expression of SEC14L4 is associated with poorer clinical outcomes, highlighting its potential as a therapeutic target and suggesting its involvement in the molecular mechanisms underlying ESCC.
Authors
- Anwaar Saeed (ORCID: https://orcid.org/0000-0001-8024-9401)
- Xu An Wang (ORCID: https://orcid.org/0000-0003-2070-4913)
- Qinyun Ma (ORCID: https://orcid.org/0000-0002-0867-2114)
- Xiaofeng Chen (ORCID: https://orcid.org/0000-0003-1333-6649)
- Yanhui Chen (ORCID: https://orcid.org/0000-0001-6511-1738)
- Youbo Wang
- Posum Wan
Institutions
- Fudan University (CN)
- University of Pittsburgh Medical Center (US)
- Huashan Hospital (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/tcr-24-1657
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57